SCHEMBL7249869

SCHEMBL7249869

CN(Cc1ccc(N(C)C)cc1)C(=O)c1ccc2c(c1)nc(CCc1ccc(C#N)cc1)n2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.49
NSD2 O96028 1/20 0.47
HDAC1 Q13547 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
PDK1 Q15118 2/20 0.41
ITK Q08881 8/20 0.41
AURKA O14965 1/20 0.41
MAP4K4 O95819 1/20 0.41
CHEK2 O96017 1/20 0.41
PRKCG P05129 1/20 0.41
PHKG2 P15735 1/20 0.41
MARK3 P27448 1/20 0.41
FLT3 P36888 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CSNK1D P48730 1/20 0.41
CLK2 P49760 1/20 0.41
GSK3B P49841 1/20 0.41
IRAK1 P51617 1/20 0.41
RPS6KA3 P51812 1/20 0.41
NEK4 P51957 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247840 0.95 NSD2 (0.52) F2NSD2HDAC1HDAC6PDK1
SCHEMBL7246372 0.86 PDK1 (0.51) F2NSD2HDAC1HDAC6PDK1
SCHEMBL7244016 0.86 F2 (0.49) F2NSD2HDAC1HDAC6ITK
Hydrochloric Acid SCHEMBL7252800 0.85 F2 (0.64) F2
SCHEMBL7244700 0.85 F2 (0.48) F2NSD2HDAC1HDAC6ITK
SCHEMBL7245070 0.82 F2 (0.53) F2HDAC1HDAC6KMT2ACNR1
SCHEMBL6486632 0.81 F2 (0.50) F2HDAC1HDAC6ITKKMT2A
SCHEMBL7252982 0.81 F2 (0.68) F2
Hydrochloric Acid SCHEMBL7244675 0.80 F2 (0.49) F2HDAC1HDAC6ITKKMT2A
SCHEMBL7244672 0.80 F2 (0.47) F2HDAC1HDAC6ITKHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed